vs

Side-by-side financial comparison of KURA SUSHI USA, INC. (KRUS) and PUMA BIOTECHNOLOGY, INC. (PBYI). Click either name above to swap in a different company.

PUMA BIOTECHNOLOGY, INC. is the larger business by last-quarter revenue ($75.5M vs $73.5M, roughly 1.0× KURA SUSHI USA, INC.). On growth, PUMA BIOTECHNOLOGY, INC. posted the faster year-over-year revenue change (27.7% vs 14.0%). PUMA BIOTECHNOLOGY, INC. produced more free cash flow last quarter ($14.4M vs $-13.3M). Over the past eight quarters, PUMA BIOTECHNOLOGY, INC.'s revenue compounded faster (31.3% CAGR vs 13.2%).

Kura Sushi, Inc. is a Japanese conveyor belt sushi restaurant chain. It is the second largest sushi restaurant chain in Japan, behind Sushiro and ahead of Hama Sushi. Its headquarters are in Sakai, Osaka Prefecture. It has 543 locations in Japan, 56 in Taiwan, and 69 in the United States.

Puma Biotechnology is a publicly traded biopharmaceutical company headquartered in Los Angeles, CA.

KRUS vs PBYI — Head-to-Head

Bigger by revenue
PBYI
PBYI
1.0× larger
PBYI
$75.5M
$73.5M
KRUS
Growing faster (revenue YoY)
PBYI
PBYI
+13.8% gap
PBYI
27.7%
14.0%
KRUS
More free cash flow
PBYI
PBYI
$27.7M more FCF
PBYI
$14.4M
$-13.3M
KRUS
Faster 2-yr revenue CAGR
PBYI
PBYI
Annualised
PBYI
31.3%
13.2%
KRUS

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
KRUS
KRUS
PBYI
PBYI
Revenue
$73.5M
$75.5M
Net Profit
$-3.1M
Gross Margin
69.3%
Operating Margin
-5.0%
22.7%
Net Margin
-4.2%
Revenue YoY
14.0%
27.7%
Net Profit YoY
-218.4%
EPS (diluted)
$-0.25
$0.26

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
KRUS
KRUS
PBYI
PBYI
Q4 25
$73.5M
$75.5M
Q3 25
$79.4M
$54.5M
Q2 25
$74.0M
$52.4M
Q1 25
$64.9M
$46.0M
Q4 24
$64.5M
$59.1M
Q3 24
$66.0M
$80.5M
Q2 24
$63.1M
$47.1M
Q1 24
$57.3M
$43.8M
Net Profit
KRUS
KRUS
PBYI
PBYI
Q4 25
$-3.1M
Q3 25
$2.3M
$8.8M
Q2 25
$565.0K
$5.9M
Q1 25
$-3.8M
$3.0M
Q4 24
$-961.0K
Q3 24
$-5.2M
$20.3M
Q2 24
$-558.0K
$-4.5M
Q1 24
$-998.0K
$-4.8M
Gross Margin
KRUS
KRUS
PBYI
PBYI
Q4 25
69.3%
Q3 25
77.7%
Q2 25
76.5%
Q1 25
77.1%
Q4 24
76.4%
Q3 24
63.9%
Q2 24
77.4%
Q1 24
75.5%
Operating Margin
KRUS
KRUS
PBYI
PBYI
Q4 25
-5.0%
22.7%
Q3 25
1.8%
17.6%
Q2 25
-0.2%
12.7%
Q1 25
-7.1%
8.7%
Q4 24
-2.3%
22.6%
Q3 24
-8.8%
27.4%
Q2 24
-1.9%
-4.6%
Q1 24
-2.9%
-5.3%
Net Margin
KRUS
KRUS
PBYI
PBYI
Q4 25
-4.2%
Q3 25
2.9%
16.2%
Q2 25
0.8%
11.2%
Q1 25
-5.8%
6.5%
Q4 24
-1.5%
Q3 24
-7.9%
25.2%
Q2 24
-0.9%
-9.6%
Q1 24
-1.7%
-11.0%
EPS (diluted)
KRUS
KRUS
PBYI
PBYI
Q4 25
$-0.25
$0.26
Q3 25
$0.18
$0.17
Q2 25
$0.05
$0.12
Q1 25
$-0.31
$0.06
Q4 24
$-0.08
$0.40
Q3 24
$-0.47
$0.41
Q2 24
$-0.05
$-0.09
Q1 24
$-0.09
$-0.10

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
KRUS
KRUS
PBYI
PBYI
Cash + ST InvestmentsLiquidity on hand
$50.7M
$97.5M
Total DebtLower is stronger
$22.7M
Stockholders' EquityBook value
$229.2M
$130.3M
Total Assets
$443.5M
$216.3M
Debt / EquityLower = less leverage
0.17×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
KRUS
KRUS
PBYI
PBYI
Q4 25
$50.7M
$97.5M
Q3 25
$62.5M
$94.4M
Q2 25
$60.5M
$96.0M
Q1 25
$85.2M
$93.2M
Q4 24
$107.7M
$101.0M
Q3 24
$51.0M
$96.7M
Q2 24
$60.7M
$96.8M
Q1 24
$62.8M
$107.2M
Total Debt
KRUS
KRUS
PBYI
PBYI
Q4 25
$22.7M
Q3 25
$34.0M
Q2 25
$45.3M
Q1 25
$56.7M
Q4 24
$68.0M
Q3 24
$79.3M
Q2 24
$90.7M
Q1 24
$102.0M
Stockholders' Equity
KRUS
KRUS
PBYI
PBYI
Q4 25
$229.2M
$130.3M
Q3 25
$231.1M
$115.3M
Q2 25
$227.0M
$104.7M
Q1 25
$225.0M
$97.1M
Q4 24
$227.6M
$92.1M
Q3 24
$162.5M
$71.1M
Q2 24
$166.4M
$48.5M
Q1 24
$165.3M
$51.0M
Total Assets
KRUS
KRUS
PBYI
PBYI
Q4 25
$443.5M
$216.3M
Q3 25
$430.9M
$202.9M
Q2 25
$419.4M
$194.9M
Q1 25
$410.4M
$196.2M
Q4 24
$403.8M
$213.3M
Q3 24
$328.5M
$220.7M
Q2 24
$324.7M
$205.0M
Q1 24
$315.5M
$214.1M
Debt / Equity
KRUS
KRUS
PBYI
PBYI
Q4 25
0.17×
Q3 25
0.30×
Q2 25
0.43×
Q1 25
0.58×
Q4 24
0.74×
Q3 24
1.12×
Q2 24
1.87×
Q1 24
2.00×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
KRUS
KRUS
PBYI
PBYI
Operating Cash FlowLast quarter
$529.0K
$14.4M
Free Cash FlowOCF − Capex
$-13.3M
$14.4M
FCF MarginFCF / Revenue
-18.1%
19.1%
Capex IntensityCapex / Revenue
18.8%
0.0%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-27.5M
$41.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
KRUS
KRUS
PBYI
PBYI
Q4 25
$529.0K
$14.4M
Q3 25
$9.4M
$9.7M
Q2 25
$6.7M
$14.1M
Q1 25
$4.3M
$3.6M
Q4 24
$4.4M
$15.6M
Q3 24
$669.0K
$11.0M
Q2 24
$8.7M
$1.0M
Q1 24
$3.8M
$11.2M
Free Cash Flow
KRUS
KRUS
PBYI
PBYI
Q4 25
$-13.3M
$14.4M
Q3 25
$-79.0K
$9.7M
Q2 25
$-6.9M
$14.1M
Q1 25
$-7.3M
$3.6M
Q4 24
$-7.2M
$15.6M
Q3 24
$-9.6M
$11.0M
Q2 24
$-2.4M
$1.0M
Q1 24
$-9.7M
FCF Margin
KRUS
KRUS
PBYI
PBYI
Q4 25
-18.1%
19.1%
Q3 25
-0.1%
17.7%
Q2 25
-9.3%
26.8%
Q1 25
-11.2%
7.7%
Q4 24
-11.2%
26.4%
Q3 24
-14.6%
13.7%
Q2 24
-3.8%
2.1%
Q1 24
-16.9%
Capex Intensity
KRUS
KRUS
PBYI
PBYI
Q4 25
18.8%
0.0%
Q3 25
11.9%
0.0%
Q2 25
18.4%
0.0%
Q1 25
17.8%
0.1%
Q4 24
17.9%
0.0%
Q3 24
15.6%
0.0%
Q2 24
17.6%
0.0%
Q1 24
23.5%
0.0%
Cash Conversion
KRUS
KRUS
PBYI
PBYI
Q4 25
Q3 25
4.12×
1.10×
Q2 25
11.88×
2.41×
Q1 25
1.21×
Q4 24
Q3 24
0.54×
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons